Hosur, India

Srinivasan Thangathirupathy

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 8.7

ph-index = 2

Forward Citations = 25(Granted Patents)


Location History:

  • Bengaluru, IN (2014 - 2019)
  • Hosur, IN (2015 - 2022)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: **Inventor Profile: Srinivasan Thangathirupathy**

Introduction

Srinivasan Thangathirupathy is a prominent inventor based in Hosur, India, known for his significant contributions to the field of pharmaceutical innovations. With a portfolio of 12 patents, he has demonstrated his expertise in developing compounds that have the potential to address critical health challenges.

Latest Patents

His latest patents focus on the "Inhibitors of indoleamine 2,3-dioxygenase and methods of their use." These patents disclose compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO). The pharmaceutical compositions containing these compounds are aimed at treating proliferative disorders, such as cancer, viral infections, and inflammatory disorders.

Career Highlights

Srinivasan has worked with distinguished companies such as Bristol-Myers Squibb Company and Syngene International Limited. His experience at these organizations has equipped him with a wealth of knowledge in drug development and innovative research methodologies.

Collaborations

Throughout his career, Srinivasan has collaborated with notable colleagues, including Srinivas Cheruku and Jayakumar Sankara Warrier. These partnerships have played a crucial role in his research endeavors and patent developments.

Conclusion

Srinivasan Thangathirupathy's work in the pharmaceutical industry has garnered recognition and respect, particularly for his innovative solutions to complex medical issues. His contributions, encapsulated in his patents, continue to shape the landscape of therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…